Framework for FDA’s Real-World Evidence Program – Mar 15, 2019

(49:45)

The FDA's Tools to Tackle the JUUL Epidemic - February 26, 2019

(27:3)

Gottlieb Breaks Down FDA’s 2019 Priorities With Bloomberg Law

(19:49)

Frequent US FDA Observations 2019 \u0026 How to Respond to FDA

(2:30:1econd)

Introduction (1/9) FDA MyStudies Mobile App System – May 9, 2019

(15:38)

FDA Study Data Technical Conformance Guide v4.4 - Nov 22, 2019

(1:9:42)

Why Banning Red No. 3 In America Took Decades | Ultra-Processed Life | Business Insider

(18:5)

The FDA Drug Development Process: GLP, GMP and GCP Regulations

(1:31:6)

Why is the FDA banning artificial coloring red three in food?

(4:43)

September 26, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

(9:31)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

(4:38:30)

FDA Inspection Do and Don't List

(23:50)

November 19, 2024 Joint Meeting of the DSaRM and the PDAC

(8:52:38)

FDA Pharmaceutical Validation Guidance and ICH: What you must know

(8:49)

Why Does The FDA Exist?

(4:11)

FDA License To Operate as Cosmetic Trader Part 1

(17:45)

CDER FDA Exclusivity – Which One Is for Me? - June 10, 2019

(1:50)

Panel Questions and Discussion (16of19) PDL – Dec.4-5, 2019

(15:35)

FDA allows standalone use of nasal spray antidepressant Spravato

(29)

FDA Approval in Breast Cancer, Review Period Extended in AML, 2019 AACR Highlights, and More

(10:)

FDA Fireside Chat Panel at Ophthalmology Innovation Summit @ ASCRS 2019

(20:53)

02/04/2019 - FDA’s Goals for the NASEM Study

(22:43)

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret...

(3:1econd)

FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arth...

(3:1econd)

Response Server Technical Overview (6/9) FDA MyStudies App – May 9, 2019

(23:49)

FDA Orphan Drugs Program and Financial Incentives for CDER Medical Products- June 10, 2019

(43:23)

2019 CCTS FDA Conference - Defining and Managing Risks using Corrective Action

(53:15)

2019 CCTS FDA Conference - View from Ground Zero: Lessons in Developing Biologic Therapeutics

(59:10)

Drug Coated Device Controversies post FDA Warning - March 27, 2019

(1:4:31)

2019 CCTS FDA Conference - Introduction

(12:3)